Throwback Tuesday! | Is Differin Gel an Anti-Aging Secret?
Differin gel Back in 2017, Yahoo! Lifestyle published an article naming Differin Gel (adapalene 0.1%) the “best drugstore anti-aging product.” This recognition sparked an important discussion: Should dermatologists recommend an over-the-counter (OTC) acne product to help patients with fine lines and wrinkles? For an expert opinion at the time of publication, Next Steps in Derm consulted board- …
Differin gel
The Derm/Rheum Clinic: Treatment Strategies for Patients with Cutaneous Autoimmune Disease
cutaneous autoimmune diseaseEffective treatment strategies are available for cutaneous autoimmune disease, according to Dr. Anthony Fernandez, director of medical and inpatient dermatology at the Cleveland Clinic. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Fernandez, who explains how the severity of the disease impacts the most appropriate treatment option. …
cutaneous autoimmune disease
Friday Pop Quiz 7/19/2024
A 59 year old African American woman presents with the following lesion. She states she is currently applying topical clobetasol and takes oral hydroxychloroquine, prednisone, and mycophenolate daily. She is interested in discussing ways to improve the appearance of this lesion. Which of the following is NOT true? A. Patient should contine with strict photoprotection given the photosensitiv …
Using Lasers & EBDs for Acne Scars in Patients with Skin of Color
acne scarsAt the 2023 Skin of Color Update conference in New York City, renowned expert Dr. Gilly Munavalli delved into the application of lasers and energy-based devices for treating acne scars, particularly focusing on patients with skin of color. Here, you can find a simplified overview of the key insights shared during the meeting for those who may have missed it. Dr. Munavalli shared that his practi …
acne scars
Treatment of Advanced Basal Cell Carcinoma With Involvement of the Left Orbit
basal cell carcinomaINTRODUCTION Periocular basal cell carcinoma (BCC) is the most common eyelid malignancy concomitant with ocular morbidity and quality of life impact.1,2 Orbital invasion occurs in 2% of cases and poses challenges for management.1,3 JDD authors highlight a multidisciplinary approach to the treatment of advanced periocular BCC.   CASE JDD authors discuss a 56-year-old male who presente …
basal cell carcinoma